Board Member
Sarepta Therapeutics, Inc. (SRPT)Equibles does not estimate personal net worth.
Get an email with a short summary when Sarepta Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SRPT alertsDouglas Ingram is recorded as Board Member at Sarepta Therapeutics, Inc. (SRPT) since January 1, 2017 and CEO at Sarepta Therapeutics, Inc. (SRPT). The proxy statement of Sarepta Therapeutics, Inc. reports total compensation of $1,387,072 for Douglas Ingram in fiscal 2019, including a base salary of $650,000. Disclosed compensation is on record for 3 fiscal years. Douglas Ingram has spoken on 5 earnings calls across 1 company, most recently for Sarepta Therapeutics, Inc. on July 16, 2025. Sarepta Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sarepta Therapeutics, Inc. includes Michael Severino, M.D. (CEO and Board Member), M. Kathleen Behrens (Chairman), Ryan H. Wong (CFO) and 7 others.
“So first, before I begin, please note that we will be making forward-looking statements today. As always, please refer to our various public filings for the risks and uncertainties that come when making predictions about the future.”
“As I mentioned at the beginning of this call, given the stage of our BLA supplement review, we're in a quiet period right now, and we cannot entertain questions this evening.”
“And by the way, everyone, it was Fran's birthday yesterday, so Happy Birthday, Fran. And good afternoon, everyone, and thank you for joining Sarepta Therapeutics' fourth quarter 2023 financial results conference call.”
“Good afternoon, and thank you for joining Sarepta Therapeutics’ third quarter 2023 financial results conference call. It was only two days ago that we announced the results of our double-blind placebo-controlled trial EMBARK.”
“Good afternoon, everyone, and thank you for joining Sarepta Therapeutics First Quarter 2021 Investor Conference Call.”
2017-01-01–present
Biotechnology · Healthcare
CEO, Board Member
2017-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Sarepta Therapeutics, Inc. (SRPT) | President and Chief Executive Officer ^^ | $650,000 | $1,387,072 |
| 2018 | Sarepta Therapeutics, Inc. (SRPT) | President and Chief Executive Officer ^^ | $650,000 | $1,433,872 |
| 2017 | Sarepta Therapeutics, Inc. (SRPT) | President and Chief Executive Officer ^^ | $337,500 | $56,866,241 |
